Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data

Siegel, 2017, Colorectal cancer statistics, 2017, CA Cancer J Clin, 67, 177, 10.3322/caac.21395

Xiong, 2017, Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data, Biomed Res Int, 2017, 10.1155/2017/2421459

Shibutani, 2018, Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in patients with Stage IV Colorectal Cancer, In Vivo, 32, 151

Kindler, 2001, Metastatic colorectal cancer, Curr Treat Options Oncol, 2, 459, 10.1007/s11864-001-0068-7

Sveen, 2011, Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival, Genome Med, 3, 32, 10.1186/gm248

Xiong, 2017, An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer, Oncotarget, 8, 85463, 10.18632/oncotarget.20013

Guinney, 2015, The consensus molecular subtypes of colorectal cancer, Nat Med, 21, 1350, 10.1038/nm.3967

Marisa, 2013, Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value, PLoS Med, 10, 10.1371/journal.pmed.1001453

Zhang, 2013, Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis, Lancet Oncol, 14, 1295, 10.1016/S1470-2045(13)70491-1

Salazar, 2011, Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer, Journal of Clinical Oncology, 29, 17, 10.1200/JCO.2010.30.1077

Watanabe, 2009, Gene expression signature for recurrence in stage III colorectal cancers, Cancer, 115, 283, 10.1002/cncr.24023

Smolle, 2014, Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer, Int J Mol Sci, 15, 13993, 10.3390/ijms150813993

Roock, 2011, KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer, Lancet Oncol, 12, 594, 10.1016/S1470-2045(10)70209-6

Frankish, 2015, Comparison of GENCODE and RefSeq gene annotation and the impact of reference geneset on variant effect prediction, BMC Genomics, 16, S2, 10.1186/1471-2164-16-S8-S2

Harrow, 2012, GENCODE: the reference human genome annotation for the ENCODE Project, Genome Res, 22, 1760, 10.1101/gr.135350.111

Biamonti, 2014, The alternative splicing side of cancer, Semin Cell Dev Biol, 32, 30, 10.1016/j.semcdb.2014.03.016

Climente-Gonzalez, 2017, The Functional Impact of Alternative Splicing in Cancer, Cell Rep, 20, 2215, 10.1016/j.celrep.2017.08.012

Lee, 2016, Therapeutic targeting of splicing in cancer, Nat Med, 22, 976, 10.1038/nm.4165

Feng, 2013, Opportunities and methods for studying alternative splicing in cancer with RNA-Seq, Cancer Lett, 340, 179, 10.1016/j.canlet.2012.11.010

Ladomery, 2013, Aberrant alternative splicing is another hallmark of cancer, Int J Cell Biol, 2013, 10.1155/2013/463786

Mojica, 2010, Normal colon epithelium: a dataset for the analysis of gene expression and alternative splicing events in colon disease, BMC Genomics, 11, 5, 10.1186/1471-2164-11-5

Bisognin, 2014, An integrative framework identifies alternative splicing events in colorectal cancer development, Mol Oncol, 8, 129, 10.1016/j.molonc.2013.10.004

Tomczak, 2015, The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge, Contemporary oncology (Poznan Poland), 19, A68

Ryan, 2012, SpliceSeq: a resource for analysis and visualization of RNA-Seq data on alternative splicing and its functional impacts, Bioinformatics, 28, 2385, 10.1093/bioinformatics/bts452

Wang, 2016, A Practical Guide to the Cancer Genome Atlas (TCGA), Methods Mol Biol, 1418, 111, 10.1007/978-1-4939-3578-9_6

Zhu, 2018, Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer, Gynecol Oncol, 148, 368, 10.1016/j.ygyno.2017.11.028

Li, 2017, Prognostic alternative mRNA splicing signature in non-small cell lung cancer, Cancer Lett, 393, 40, 10.1016/j.canlet.2017.02.016

Conway, 2017, UpSetR: an R package for the visualization of intersecting sets and their properties, Bioinformatics, 33, 2938, 10.1093/bioinformatics/btx364

Gu, 2014, Circlize Implements and enhances circular visualization in R, Bioinformatics, 30, 2811, 10.1093/bioinformatics/btu393

Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, Omics : a journal of integrative biology, 16, 284, 10.1089/omi.2011.0118

Su, 2014, Biological network exploration with Cytoscape 3, Curr Protoc Bioinformatics, 47, 8.13.1, 10.1002/0471250953.bi0813s47

Giulietti, 2013, SpliceAid-F: a database of human splicing factors and their RNA-binding sites, Nucleic Acids Res, 41, D125, 10.1093/nar/gks997

Langfelder, 2008, WGCNA: an R package for weighted correlation network analysis, BMC Bioinformatics, 9, 559, 10.1186/1471-2105-9-559

Wilkerson, 2010, ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking, Bioinformatics, 26, 1572, 10.1093/bioinformatics/btq170

Eide, 2017, CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models, Sci Rep, 7, 16618, 10.1038/s41598-017-16747-x

Thorsen, 2008, Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis, Molecular & Cellular Proteomics, 7, 1214, 10.1074/mcp.M700590-MCP200

Gardina, 2006, Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array, BMC Genomics, 7, 325, 10.1186/1471-2164-7-325

Yang, 2016, Widespread expansion of Protein Interaction Capabilities by Alternative Splicing, Cell, 164, 805, 10.1016/j.cell.2016.01.029

Dienstmann, 2017, Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer, Nat Rev Cancer, 17, 79, 10.1038/nrc.2016.126

Moore, 2010, An alternative splicing network links cell-cycle control to apoptosis, Cell, 142, 625, 10.1016/j.cell.2010.07.019

Blencowe, 2006, Alternative splicing: new insights from global analyses, Cell, 126, 37, 10.1016/j.cell.2006.06.023

De Rosa, 2007, Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript, Gene, 395, 8, 10.1016/j.gene.2006.10.027

Patek, 2008, The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine, BMC Gastroenterol, 8, 24, 10.1186/1471-230X-8-24

Luo, 2010, K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation, J Pathol, 220, 542, 10.1002/path.2672

Marcel, 2009, p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity? Cellular and molecular life sciences, CMLS, 66, 391, 10.1007/s00018-008-8336-3

Marcel, 2013, Detecting p53 isoforms at protein level, Methods Mol Biol, 962, 15, 10.1007/978-1-62703-236-0_2

Bourdon, 2007, p53 and its isoforms in cancer, Br J Cancer, 97, 277, 10.1038/sj.bjc.6603886

Miura, 2012, Splice isoforms as therapeutic targets for colorectal cancer, Carcinogenesis, 33, 2311, 10.1093/carcin/bgs347

Consortium SM-I, 2014, A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium, Nat Biotechnol, 32, 903, 10.1038/nbt.2957

Yang, 2015, The impact of RNA-seq aligners on gene expression estimation, Acm Conference, 2015, 462

Liu, 2018, Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer, J Cancer, 9, 1754, 10.7150/jca.24569

Chen, 2015, Alternative splicing in cancer: implications for biology and therapy, Oncogene, 34, 1, 10.1038/onc.2013.570

Todaro, 2014, CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis, Cell Stem Cell, 14, 342, 10.1016/j.stem.2014.01.009

von Pawel, 2018, Randomized phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer, Oncologist, 23, 10.1634/theoncologist.2017-0690

Zboralski, 2017, Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade, Cancer Immunol Res, 5, 950, 10.1158/2326-6066.CIR-16-0303

Ingram, 2013, Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations, Carcinogenesis, 34, 2341, 10.1093/carcin/bgt222

Sakuma, 2018, HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition, Gut, 67, 1103, 10.1136/gutjnl-2016-312927

Akishima-Fukasawa, 2009, Prognostic significance of CXCL12 expression in patients with colorectal carcinoma, Am J Clin Pathol, 132, 202, 10.1309/AJCPK35VZJEWCUTL

Zhao, 2014, A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer1,2, Translational oncology, 7, 429, 10.1016/j.tranon.2014.04.001

Takagaki, 1990, A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs, Genes Dev, 4, 2112, 10.1101/gad.4.12a.2112

Karreth, 2013, ceRNA cross-talk in cancer: when ce-bling rivalries go awry, Cancer Discov, 3, 1113, 10.1158/2159-8290.CD-13-0202

Thomson, 2016, Endogenous microRNA sponges: evidence and controversy, Nat Rev Genet, 17, 272, 10.1038/nrg.2016.20